Literature DB >> 22791395

Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly.

Olga E Titova1, Per Sjögren, Samantha J Brooks, Joel Kullberg, Erika Ax, Lena Kilander, Ulf Riserus, Tommy Cederholm, Elna-Marie Larsson, Lars Johansson, Håkan Ahlström, Lars Lind, Helgi B Schiöth, Christian Benedict.   

Abstract

In the present study, we tested whether elderly with a high dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) would have higher cognitive test scores and greater brain volume than those with low dietary intake of these fatty acids. Data were obtained from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) cohort. The dietary intake of EPA and DHA was determined by a 7-day food protocol in 252 cognitively healthy elderly (122 females) at the age of 70 years. At age 75, participants' global cognitive function was examined, and their brain volumes were measured by magnetic resonance imaging (MRI). Three different multivariate linear regression models were applied to test our hypothesis: model A (adjusted for gender and age), model B (additionally controlled for lifestyle factors, e.g., education), and model C (further controlled for cardiometabolic factors, e.g., systolic blood pressure). We found that the self-reported 7-day dietary intake of EPA and DHA at the age of 70 years was positively associated with global gray matter volume (P < 0.05, except for model C) and increased global cognitive performance score (P < 0.05). However, no significant associations were observed between the dietary intake of EPA and DHA and global white matter, total brain volume, and regional gray matter, respectively. Further, no effects were observed when examining cognitively impaired (n = 27) elderly as separate analyses. These cross-sectional findings suggest that dietary intake of EPA and DHA may be linked to improved cognitive health in late life but must be confirmed in patient studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22791395      PMCID: PMC3705118          DOI: 10.1007/s11357-012-9453-3

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  37 in total

1.  Critical evaluation of energy intake using the Goldberg cut-off for energy intake:basal metabolic rate. A practical guide to its calculation, use and limitations.

Authors:  A E Black
Journal:  Int J Obes Relat Metab Disord       Date:  2000-09

2.  Screening for dementia by memory testing.

Authors:  E Grober; H Buschke; H Crystal; S Bang; R Dresner
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

3.  Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

Authors:  Yvonne Freund-Levi; Maria Eriksdotter-Jönhagen; Tommy Cederholm; Hans Basun; Gerd Faxén-Irving; Anita Garlind; Inger Vedin; Bengt Vessby; Lars-Olof Wahlund; Jan Palmblad
Journal:  Arch Neurol       Date:  2006-10

Review 4.  B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review.

Authors:  Alan D Dangour; Peter J Whitehouse; Kevin Rafferty; Stephen A Mitchell; Lesley Smith; Sophie Hawkesworth; Bruno Vellas
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Dietary fat intake and the risk of incident dementia in the Rotterdam Study.

Authors:  S Kalmijn; L J Launer; A Ott; J C Witteman; A Hofman; M M Breteler
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

6.  Mediterranean and carbohydrate-restricted diets and mortality among elderly men: a cohort study in Sweden.

Authors:  Per Sjögren; Wulf Becker; Eva Warensjö; Erika Olsson; Liisa Byberg; Inga-Britt Gustafsson; Brita Karlström; Tommy Cederholm
Journal:  Am J Clin Nutr       Date:  2010-09-08       Impact factor: 7.045

7.  Physical activity, including walking, and cognitive function in older women.

Authors:  Jennifer Weuve; Jae Hee Kang; JoAnn E Manson; Monique M B Breteler; James H Ware; Francine Grodstein
Journal:  JAMA       Date:  2004-09-22       Impact factor: 56.272

8.  Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk.

Authors:  Elizabeth E Devore; Francine Grodstein; Frank J A van Rooij; Albert Hofman; Bernard Rosner; Meir J Stampfer; Jacqueline C M Witteman; Monique M B Breteler
Journal:  Am J Clin Nutr       Date:  2009-05-27       Impact factor: 7.045

9.  Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress.

Authors:  Pranab K Mukherjee; Victor L Marcheselli; Charles N Serhan; Nicolas G Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-19       Impact factor: 11.205

10.  Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study.

Authors:  Boukje Maria van Gelder; Marja Tijhuis; Sandra Kalmijn; Daan Kromhout
Journal:  Am J Clin Nutr       Date:  2007-04       Impact factor: 7.045

View more
  31 in total

Review 1.  Role of polyunsaturated fatty acids in human brain structure and function across the lifespan: An update on neuroimaging findings.

Authors:  Robert K McNamara; Ruth H Asch; Diana M Lindquist; Robert Krikorian
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-05-09       Impact factor: 4.006

Review 2.  Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology.

Authors:  Robert K McNamara; Jennifer J Vannest; Christina J Valentine
Journal:  World J Psychiatry       Date:  2015-03-22

Review 3.  Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application.

Authors:  Erik Messamore; Daniel M Almeida; Ronald J Jandacek; Robert K McNamara
Journal:  Prog Lipid Res       Date:  2017-01-06       Impact factor: 16.195

4.  Dietary Factors and Cognitive Decline.

Authors:  P J Smith; J A Blumenthal
Journal:  J Prev Alzheimers Dis       Date:  2016-03

5.  Omega-3 Supplementation and the Neural Correlates of Negative Affect and Impulsivity: A Double-Blind, Randomized, Placebo-Controlled Trial in Midlife Adults.

Authors:  Annie T Ginty; Matthew F Muldoon; Dora C H Kuan; Brittney Schirda; Thomas W Kamarck; J Richard Jennings; Stephen B Manuck; Peter J Gianaros
Journal:  Psychosom Med       Date:  2017-06       Impact factor: 4.312

6.  Mediterranean diet and brain structure in a multiethnic elderly cohort.

Authors:  Yian Gu; Adam M Brickman; Yaakov Stern; Christian G Habeck; Qolamreza R Razlighi; José A Luchsinger; Jennifer J Manly; Nicole Schupf; Richard Mayeux; Nikolaos Scarmeas
Journal:  Neurology       Date:  2015-10-21       Impact factor: 9.910

7.  Regular fish consumption and age-related brain gray matter loss.

Authors:  Cyrus A Raji; Kirk I Erickson; Oscar L Lopez; Lewis H Kuller; H Michael Gach; Paul M Thompson; Mario Riverol; James T Becker
Journal:  Am J Prev Med       Date:  2014-07-29       Impact factor: 5.043

8.  White matter integrity as a mediator in the relationship between dietary nutrients and cognition in the elderly.

Authors:  Yian Gu; Robert S Vorburger; Yunglin Gazes; Christian G Habeck; Yaakov Stern; José A Luchsinger; Jennifer J Manly; Nicole Schupf; Richard Mayeux; Adam M Brickman
Journal:  Ann Neurol       Date:  2016-05-11       Impact factor: 10.422

9.  Effects of fish oil supplementation on prefrontal metabolite concentrations in adolescents with major depressive disorder: a preliminary 1H MRS study.

Authors:  Robert K McNamara; Ronald Jandacek; Therese Rider; Patrick Tso; Wen-Jang Chu; Wade A Weber; Jeffrey A Welge; Jeffrey R Strawn; Caleb M Adler; Melissa P DelBello
Journal:  Nutr Neurosci       Date:  2016-03-02       Impact factor: 4.994

10.  Fish Oil Supplementation Increases Event-Related Posterior Cingulate Activation in Older Adults with Subjective Memory Impairment.

Authors:  E L Boespflug; R K McNamara; J C Eliassen; M D Schidler; R Krikorian
Journal:  J Nutr Health Aging       Date:  2016-02       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.